Jefferies lowered the firm’s price target on Clorox (CLX) to $145 from $167 and keeps a Buy rating on the shares, telling investors that the next two quarters “will be complicated to model” as shipping timing ahead of Clorox’s U.S. ERP rollout and wind down will “create operating leverage and deleverage that surprises.” The firm, which expects Clorox to guide to down 4% to down 2% organic sales and a low-teens percentage EPS decline for FY26, thinks consensus estimates need a “recalibration” as numbers are “too high.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
